Asgard Therapeutics Revenue and Competitors
Employee Data
- Asgard Therapeutics has 26 Employees.
- Asgard Therapeutics grew their employee count by 24% last year.
Asgard Therapeutics's People
Name | Title | Email/Phone |
---|
Asgard Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 62 | 17% | N/A | N/A |
#2 | N/A | 64 | 23% | N/A | N/A |
#3 | N/A | 55 | 34% | N/A | N/A |
#4 | N/A | 26 | 24% | N/A | N/A |
#5 | N/A | 12 | 9% | N/A | N/A |
#6 | N/A | 11 | 0% | N/A | N/A |
#7 | N/A | 13 | 30% | N/A | N/A |
#8 | N/A | 12 | 200% | N/A | N/A |
#9 | N/A | 16 | 14% | N/A | N/A |
What Is Asgard Therapeutics?
Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.
keywords:N/AN/A
Total Funding
26
Number of Employees
N/A
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 26 | -19% | N/A |
#2 | $6.8M | 27 | 0% | N/A |
#3 | $2.8M | 28 | 8% | N/A |
#4 | $4.3M | 28 | -35% | N/A |
#5 | $4.1M | 29 | 190% | N/A |